arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

TransMedics Group, Inc.

TMDX Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$89.90
▼ -0.1% Today
as of Sep 4, 16:55 ET
Last 30 days +17.94% Jul 28 → Sep 04
$74.64 $80.04 $85.45 $90.86 $96.26 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$84.63
High
$90.11
Low
$83.61
Volume
$542,547
Avg Vol
$995,819
Mkt Cap
$2.8B
P/E (TTM)
70.85
Beta
—
52w High
$156.00
52w Low
$60.10
Div Yield
—
Shares Out
$35M

Recent Press Releases & News last 60 days · 22 items

Sep 3 · 18:00 Zacks
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
Sep 3 · 15:30 Zacks
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?
Aug 31 · 20:05 PR PR Newswire
TransMedics to Present at Upcoming September Investor Conferences
▸ Show all 22 press releases & news Free account →

Overview

52-week range
$60
$156
31% of range
Avg surprise (last 3)
+60.5%
Avg reaction (last 2)
-2.5%
0% positive
Latest IV / EM
50%
EM ±5.6% · $90 · Sep 11

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.78$-0.35$0.07$0.50$0.92 Actual $-0.08Actual $-0.03Actual $-0.78Actual $0.35Actual $0.35Actual $0.12Actual $0.70Est $0.29Actual $0.92Est $0.48Actual $0.66Actual $0.30Est $0.62Actual $0.41 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$50M$100M$150M$199M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.41 — — — — financials
Tue May 5, 2026Mar/2026 $0.30 $0.62 -51.6% -57.1% -2.2% earnings
Tue Sep 30, 2025Sep 2025 $0.66 — — — — financials
Wed Jul 30, 2025Jun/2025 $0.92 $0.48 +91.7% — — earnings
Thu May 8, 2025Mar/2025 $0.70 $0.29 +141.4% — -2.7% earnings
Mon Sep 30, 2024Sep 2024 $0.12 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.35 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.35 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.78 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.03 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.08 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$190M$174M—$144M$157M$144M—$109M
Cost of revenue$77M$73M—$59M$61M$55M—$48M
Gross profit$113M$101M—$85M$97M$88M—$61M
Operating income$24M$13M—$23M$37M$27M—$4M
Net income$15M$7M—$24M$35M$26M—$4M
EPS (diluted)$0.41$0.20—$0.66$0.92$0.70—$0.12

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$473M$462M$488M$466M$401M$310M—$330M
Inventory$54M$50M$49M$45M$39M$43M$47M$52M
Total current assets$651M$619M$638M$613M$558M$506M$497M$492M
Total assets$1.46B$1.43B$1.07B$946M$891M$838M$804M$786M
Long-term debt————————
Total liabilities$946M$941M$595M$591M$572M$571M$575M$576M
Total equity$518M$494M$473M$355M$318M$266M$229M$210M

Implied volatility — last 90 days

40%58%77%95%113% Jun 07 — IV 76% · EM ±10.5%Jun 08 — IV 71% · EM ±9.4%Jun 09 — IV 59% · EM ±7.4%Jun 10 — IV 71% · EM ±8.4%Jun 11 — IV 82% · EM ±9.0%Jun 12 — IV 71% · EM ±7.2%Jun 15 — IV 83% · EM ±6.0%Jun 16 — IV 102% · EM ±6.0%Jun 17 — IV 96% · EM ±4.0%Jun 19 — IV 62% · EM ±13.7%Jun 22 — IV 57% · EM ±11.8%Jun 23 — IV 70% · EM ±14.2%Jun 24 — IV 58% · EM ±11.7%Jun 25 — IV 58% · EM ±11.4%Jun 26 — IV 67% · EM ±12.9%Jun 29 — IV 60% · EM ±10.6%Jun 30 — IV 65% · EM ±11.2%Jul 01 — IV 68% · EM ±11.4%Jul 02 — IV 71% · EM ±11.5%Jul 03 — IV 74% · EM ±11.5%Jul 06 — IV 62% · EM ±8.6%Jul 07 — IV 52% · EM ±6.9%Jul 08 — IV 60% · EM ±7.5%Jul 09 — IV 64% · EM ±7.6%Jul 10 — IV 67% · EM ±7.4%Jul 13 — IV 76% · EM ±6.4%Jul 14 — IV 77% · EM ±5.6%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 71% · EM ±3.0%Jul 20 — IV 89% · EM ±21.0%Jul 21 — IV 91% · EM ±21.2%Jul 22 — IV 86% · EM ±19.8%Jul 23 — IV 83% · EM ±18.7%Jul 24 — IV 88% · EM ±19.4%Jul 27 — IV 86% · EM ±17.9%Jul 28 — IV 92% · EM ±18.8%Jul 29 — IV 96% · EM ±19.1%Jul 30 — IV 97% · EM ±19.1%Jul 31 — IV 90% · EM ±17.3%Aug 03 — IV 104% · EM ±18.4%Aug 04 — IV 113% · EM ±19.5%Aug 05 — IV 60% · EM ±10.1%Aug 06 — IV 60% · EM ±9.8%Aug 07 — IV 54% · EM ±8.4%Aug 10 — IV 61% · EM ±8.4%Aug 11 — IV 55% · EM ±7.3%Aug 12 — IV 52% · EM ±6.5%Aug 13 — IV 50% · EM ±5.9%Aug 14 — IV 52% · EM ±5.8%Aug 17 — IV 71% · EM ±5.9%Aug 18 — IV 57% · EM ±4.1%Aug 19 — IV 70% · EM ±4.1%Aug 20 — IV 67% · EM ±2.8%Aug 24 — IV 54% · EM ±11.2%Aug 25 — IV 50% · EM ±10.3%Aug 26 — IV 49% · EM ±9.7%Aug 27 — IV 46% · EM ±9.0%Aug 28 — IV 56% · EM ±10.6%Aug 31 — IV 44% · EM ±7.7%Sep 01 — IV 58% · EM ±10.0%Sep 02 — IV 52% · EM ±8.7%Sep 03 — IV 41% · EM ±4.8%Sep 04 — IV 50% · EM ±5.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in